Risk of Juvenile Idiopathic Arthritis Following HPV9 Vaccination: A Retrospective Cohort Study Before and During the COVID-19 Pandemic.
Saved in:
| Title: | Risk of Juvenile Idiopathic Arthritis Following HPV9 Vaccination: A Retrospective Cohort Study Before and During the COVID-19 Pandemic. |
|---|---|
| Authors: | Tsai MC; Department of Pediatrics, Taichung Veterans General Hospital, Taichung, Taiwan., Chen HH; Division of Allergy, Immunology and Rheumatology, Department of Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.; Department of Digital Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.; Department of Post-Baccalaureate Medicine, National Chung Hsing University, Taichung, Taiwan.; Program in Translational Medicine and Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung, Taiwan.; Big Data Center, National Chung Hsing University, Taichung, Taiwan., Wu WY; Department of Pediatrics, Taichung Veterans General Hospital, Taichung, Taiwan., Huang YC; Department of Pediatrics, Taichung Veterans General Hospital, Taichung, Taiwan.; Department of Post-Baccalaureate Medicine, National Chung Hsing University, Taichung, Taiwan., Hsu CY; Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan., Fu LS; Department of Pediatrics, Taichung Veterans General Hospital, Taichung, Taiwan.; Department of Post-Baccalaureate Medicine, National Chung Hsing University, Taichung, Taiwan. |
| Source: | Mayo Clinic proceedings. Innovations, quality & outcomes [Mayo Clin Proc Innov Qual Outcomes] 2025 Sep 09; Vol. 9 (5), pp. 100647. Date of Electronic Publication: 2025 Sep 09 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: Netherlands NLM ID: 101728275 Publication Model: eCollection Cited Medium: Internet ISSN: 2542-4548 (Electronic) Linking ISSN: 25424548 NLM ISO Abbreviation: Mayo Clin Proc Innov Qual Outcomes Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
